Patent: 7,762,994

✉ Email this page to a colleague

Summary for Patent: 7,762,994

Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,762,994
Patent Claims:	see list of patent claims

Details for Patent 7,762,994

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005	7,762,994
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013	7,762,994
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	7,762,994
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	November 21, 2018	7,762,994
Novo Nordisk Inc.	FIASP	insulin aspart	Injection	208751	September 29, 2017	7,762,994
Novo Nordisk Inc.	FIASP	insulin aspart	Injection	208751	September 24, 2018	7,762,994
Novo Nordisk Inc.	FIASP	insulin aspart	Injection	208751	June 21, 2023	7,762,994
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.